GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

FO Alenazy, MH Harbi, DP Kavanagh… - European Heart …, 2021 - academic.oup.com
Introduction Aspirin and a potent platelet P2Y12 inhibitor, such as prasugrel or ticagrelor,
are not always sufficient to prevent thrombus formation in patients with ST-elevation MI …
被引用次数：6 相关文章

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

F Alenazy, M Harbi, D Kavanagh, J Price, P Harrison… - escardio.org
GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced
platelet activation when combined with co Page 1 GPVI inhibition by glenzocimab …

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

FO Alenazy, MH Harbi, DP Kavanagh, J Price, P Brady… - academia.edu
Methods: We used intravital microscopy in a murine model of ST-elevation myocardial
infarction and ischaemia-reperfusion injury to investigate microvascular thrombosis. We …

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

scholar.archive.org
Methods: We used intravital microscopy in a murine model of ST-elevation myocardial
infarction and ischaemia-reperfusion injury to investigate microvascular thrombosis. We …

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

FO Alenazy, MH Harbi, DP Kavanagh… - European Heart …, 2021 - academic.oup.com
Introduction Aspirin and a potent platelet P2Y12 inhibitor, such as prasugrel or ticagrelor,
are not always sufficient to prevent thrombus formation in patients with ST-elevation MI …

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

researchgate.net
Methods: We used intravital microscopy in a murine model of ST-elevation myocardial
infarction and ischaemia-reperfusion injury to investigate microvascular thrombosis. We …

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

FO Alenazy, MH Harbi, DP Kavanagh, J Price, P Brady… - academia.edu
Methods: We used intravital microscopy in a murine model of ST-elevation myocardial
infarction and ischaemia-reperfusion injury to investigate microvascular thrombosis. We …